VCRE

Vicore Pharma Holding AB ADR

8.97

Oct 13 • 3:23 PM ET -0.26 (-2.82%)

Healthcare Biotechnology Sweden Micro NASD

Peers: BDRX ELOX SCNI BBLG SLXN VBIO GNPX MBRX AZTR OGEN

Index	-
Market Cap	252.60M
Enterprise Value	159.02M
Income	-53.63M
Sales	0.43M
Book/sh	3.13
Cash/sh	3.32
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	37
IPO	Jul 06, 2026

P/E	-
Forward P/E	-
PEG	-
P/S	587.43
P/B	2.86
P/C	2.70
P/FCF	-
EV/EBITDA	-
EV/Sales	369.80
Quick Ratio	12.68
Current Ratio	12.68
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	-2.04
EPS next Y	-1.64
EPS next Q	-0.53
EPS this Y	10.50%
EPS next Y	14.66%
EPS next 5Y	2.32%
EPS past 3/5Y	19.15% 6.64%
Sales past 3/5Y	- -
EPS Y/Y TTM	-11.59%
Sales Y/Y TTM	-42.16%
EPS Q/Q	-6.51%
Sales Q/Q	30.84%
Earnings	Aug 21 BMO
EPS/Sales Surpr.	-27.23% -

Insider Own	-
Insider Trans	-
Inst Own	-
Inst Trans	36.72%
ROA	-54.03%
ROE	-58.46%
ROIC	-60.81%
Gross Margin	-
Oper. Margin	-13128.66%
Profit Margin	-12573.17%
SMA20	-6.03%
SMA50	-16.84%
SMA200	-20.21%
Trades

Shs Outstand	28.15M
Shs Float	-
Short Float	-
Short Ratio	0.23
Short Interest	0.00M
52W High	17.80 -49.61%
52W Low	7.88 13.83%
Volatility	8.84% 7.81%
ATR (14)	0.70
RSI (14)	32.46
Beta	-
Rel Volume	1.40
Avg Volume	18.21K
Volume	23,237

Perf Week	2.63%
Perf Month	-19.62%
Perf Quarter	-27.54%
Perf Half Y	-
Perf YTD	-39.80%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	28.43
Prev Close	9.23
Price	8.97
Change %	-2.82%

Today 02:20AM	Vicore Pharma to Participate in the Chardan Healthcare Conference (ACCESSWIRE)
Sep-30-26 03:20AM	Increase in Number of Shares and Votes in Vicore Pharma (ACCESSWIRE)
Sep-17-26 02:20AM	Vicore Pharma to Present in The Stifel 2026 Virtual Immunology and Inflammation Forum (ACCESSWIRE)
Sep-01-26 02:20AM	Vicore Pharma to Participate in Upcoming Healthcare Conferences (ACCESSWIRE)
Aug-26-26 02:20AM	Vicore Pharma to Present at The Pareto Securities 17th Annual Healthcare Conference (ACCESSWIRE)
02:15AM	Loading…
Aug-24-26 02:15AM	Vicore Pharma to Present at the European Respiratory Society Congress 2026 (ACCESSWIRE) -8.00%
Jul-07-26 02:20AM	Vicore Pharma to Participate in the Leerink Therapeutics Forum (ACCESSWIRE) -7.54%

Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Its drug development programs include VP01, VP02, VP03, and VP04. The company was founded in 2000 sand is headquartered in Stockholm, Sweden.

Chief Executive OfficerMr. Ahmed S. Mousa J.D.

Chief Financial OfficerMr. Hans Jeppsson Ph.D.

Chief Operating OfficerMr. Mikael Nygard

Chief Technology OfficerMs. Helen Barker

Chief Scientific OfficerDr. Rob Slack Ph.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

VCRE

Vicore Pharma Holding AB ADR

Upgrade your Finviz experience